The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Nov. 22, 2016
Filed:
Mar. 11, 2014
Applicants:
David Bryant Batt, Wayland, MA (US);
Seth Alexander Ettenberg, Melrose, MA (US);
Nicole Haubst, Munich, DE;
Tiancen HU, Cambridge, MA (US);
David Jenkins, Carlisle, MA (US);
Engin Toksoz, Munich, DE;
Konstantin Petropoulos, Munich, DE;
Matthew John Meyer, Framingham, MA (US);
Inventors:
David Bryant Batt, Wayland, MA (US);
Seth Alexander Ettenberg, Melrose, MA (US);
Nicole Haubst, Munich, DE;
Tiancen Hu, Cambridge, MA (US);
David Jenkins, Carlisle, MA (US);
Engin Toksoz, Munich, DE;
Konstantin Petropoulos, Munich, DE;
Matthew John Meyer, Framingham, MA (US);
Assignee:
Novartis AG, Basel, CH;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/48 (2006.01); C07K 16/28 (2006.01); A61K 45/06 (2006.01); A61K 49/00 (2006.01); A61K 51/10 (2006.01);
U.S. Cl.
CPC ...
A61K 45/06 (2013.01); A61K 47/48092 (2013.01); A61K 47/48384 (2013.01); A61K 47/48561 (2013.01); A61K 47/48676 (2013.01); A61K 49/0004 (2013.01); A61K 51/103 (2013.01); C07K 16/2863 (2013.01); C07K 2317/21 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract
The present invention relates to anti-FGFR2 and FGFR4 antibodies, antibody fragments, antibody drug conjugates, and their uses for the treatment of cancer.